Quantbot Technologies’s Mineralys Therapeutics MLYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$131K Buy
+5,216
New +$142K ﹤0.01% 1477
2025
Q4
– Sell
-39
Closed -$1.48K – 1994
2025
Q3
$1.48K Buy
+39
New +$844 ﹤0.01% 1667

Other funds holding MLYS

Quantbot Technologies's MLYS Position: Q3 2026 in Review

Quantbot Technologies opened a new position in Mineralys Therapeutics (MLYS) in Q3 2026: 5,216 shares worth $131K. The stake represents ﹤0.01% of the portfolio and ranks #1477 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in MLYS as recently as Q3 2025.

Quantbot Technologies first reported a position in MLYS in Q3 2025 and has held it in 2 quarters since. 219 funds tracked by Wall St. Rank hold MLYS as of Q3 2026.

  • Quantbot Technologies held 5,216 shares of Mineralys Therapeutics worth $131K as of Q3 2026.
  • Mineralys Therapeutics was a new Quantbot Technologies position in Q3 2026.
  • Mineralys Therapeutics made up ﹤0.01% of Quantbot Technologies's portfolio in Q3 2026, its #1477 holding.
  • Quantbot Technologies first reported a position in Mineralys Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • 219 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q3 2026.

Based on Quantbot Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.